Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention

The article presents modern approaches to choosing a P2Y12 inhibitor as part of combined antithrombotic therapy in patients with acute coronary syndrome, depending on the indications for interventional treatment and the presence of comorbidities such as atrial fibrillation and diabetes.

Saved in:
Bibliographic Details
Published inRossiĭskiĭ kardiologicheskiĭ zhurnal Vol. 25; no. 7; p. 3809
Main Authors Golosova, A. N., Gatsura, S. V., Ulyanova, E. A., Dvoryanchikova, Zh. Yu
Format Journal Article
LanguageEnglish
Russian
Published FIRMA «SILICEA» LLC 15.08.2020
Subjects
acute coronary syndrome
clopidogrel
dual antiplatelet therapy
percutaneous coronary intervention
prasugrel
ticagrelor
Online AccessGet full text

Cover

More Information
Summary:The article presents modern approaches to choosing a P2Y12 inhibitor as part of combined antithrombotic therapy in patients with acute coronary syndrome, depending on the indications for interventional treatment and the presence of comorbidities such as atrial fibrillation and diabetes.
ISSN:1560-4071
2618-7620
DOI:10.15829/1560-4071-2020-3809